MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-02-0030203
Cadicare Pharmaceuticals Private Limited
Cadicare Pharmaceuticals Private Limited - trading in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹39.29 Lakh
▲ 4% YoY
Net loss · FY 2024
₹1.68 Lakh
Net margin -4.3%
EBITDA · FY 2024
₹28,930
EBITDA margin 0.7%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
About Cadicare Pharmaceuticals Private Limited
Data last updated:
Cadicare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 28 September 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2006PTC154448. Its GSTIN is 08AACCC9770C1ZN (Rajasthan).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manoj Bhargava and Sameer Pathak.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 36 Hargovind Vihar Sector No. – 4 Rohini, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹39.29 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net loss of ₹1.68 Lakh (net margin -4.3%) and EBITDA of ₹28,930 (EBITDA margin 0.7%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Cadicare Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0030203). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232DL2006PTC154448
Registration Number 154448
Incorporation Date 28 September 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-02-0030203
Key People
Manoj Bhargava Director Sameer Pathak Director Recognitions & Rankings of Cadicare Pharmaceuticals
Contact details
Cadicare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 36 Hargovind Vihar Sector No. – 4 Rohini, New Delhi, Delhi, India – 110085
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Cadicare Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cadicare Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cadicare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cadicare Pharmaceuticals Private Limited, buy the company report.
Financials of Cadicare Pharmaceuticals Private Limited
FY 2025 filings availableCadicare Pharmaceuticals Private Limited reported revenue of ₹39.29 Lakh (up 4% YoY) for FY 2024.
Revenue · FY 2024
₹39.29 Lakh ▲ 4%
Net loss · FY 2024
₹1.68 Lakh margin -4.3%
EBITDA · FY 2024
₹28,930 margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 6%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 81%
3 years · compounded
▼ 26%
5 years · compounded
▼ 27%
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 5%. EBITDA fell 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28,930 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.68 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | -4.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cadicare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cadicare Pharmaceuticals Private Limited
Cadicare Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Bhargava | Director | 28 Sep 2006 | 20 Years 0 Months | Current |
| Sameer Pathak | Director | 28 Sep 2006 | 20 Years 0 Months | Current |
Peer comparison
Cadicare Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asap Pharmaceuticals Private Limited | ₹39.48 Lakh (FY 2025) | 5.0% | Patna, Bihar, India | |||
| Acuva Pharmaceuticals Private Limited | ₹39.4 Lakh (FY 2025) | -12.0% | Bhubaneswar, Odisha, India | |||
| Cadicare Pharmaceuticals Private Limitedthis company | ₹39.29 Lakh (FY 2024) | -₹1.68 Lakh | -4.3% | 4.0% | New Delhi, Delhi, India | |
| Spenduo Pharmaceuticals Private Limited | ₹39.15 Lakh (FY 2020) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Cadicare Pharmaceuticals Private Limited, buy the company report.
Auditor
Cadicare Pharmaceuticals Private Limited is audited by AJAY INDERLAL AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AJAY INDERLAL AND ASSOCIATES | FY 2017 | 009468C |
Shareholding
The shareholding of Cadicare Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cadicare Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 May 2021 | 100465198 | Canara Bank | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cadicare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cadicare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cadicare Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCC9770C1ZN | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cadicare Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cadicare Pharmaceuticals Private Limited has 4 board changes on record since 2006: 2 appointments and 2 cessations. The latest: Ravindra Kumar Jain ceased to be Director on 24 Feb 2016.
AGM
Cadicare Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cadicare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Canara Bank amounted to Rs. 10.00 Lakh with Charge ID 100465198 was registered on 21 May 2021.
Ceased
Ravindra Kumar Jain ceased to be Director.
Ceased
Shri Prakash Agarwal ceased to be Director.
Appointed
Manoj Bhargava was appointed as Director.
Appointed
Sameer Pathak was appointed as Director.
Incorporation
28 Sep 2006
Cadicare Pharmaceuticals Private Limited was registered on 28 Sep 2006 with Roc Delhi Ii & aged 20 years 26 days as per MCA records.
Frequently asked questions
Cadicare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 28 September 2006 (20+ years old) and is registered under CIN U24232DL2006PTC154448.
Cadicare Pharmaceuticals has 2 current directors:
- Manoj Bhargava - Director
- Sameer Pathak - Director
The latest financial statements of Cadicare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cadicare Pharmaceuticals is 08AACCC9770C1ZN, registered in Rajasthan.
The CIN (Corporate Identification Number) of Cadicare Pharmaceuticals is U24232DL2006PTC154448. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadicare Pharmaceuticals was incorporated on 28 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cadicare Pharmaceuticals by revenue are Asap Pharmaceuticals Private Limited, Acuva Pharmaceuticals Private Limited, Spenduo Pharmaceuticals Private Limited, all in the Healthcare industry (Alternative Medicine, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ravindra Kumar Jain ceased to be Director on 24 Feb 2016. Shri Prakash Agarwal ceased to be Director on 02 Feb 2009. Manoj Bhargava was appointed as Director on 28 Sep 2006. Cadicare Pharmaceuticals has 4 board changes on record in total.
Yes, Cadicare Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-02-0030203).
The registered office of Cadicare Pharmaceuticals is at A – 36 Hargovind Vihar Sector No. – 4 Rohini, New Delhi, Delhi, India – 110085.
Cadicare Pharmaceuticals operates in the trading industry, in the other wholesale segment.